No Signs of the DOJ Letting Off the Pedal with Medicare Fraud Investigations
However, a new memo instructs federal prosecutors to ‘avoid overreach’ when parties cooperate with authorities
National Lab Reporter
Keeps You Up-to-Date on Federal & State Laws, Regulations, New Legislation, and Court Cases that Affect Your Diagnostic Lab or Pathology Practice
Subscribe today for access to
Articles and Reports
Next Steps: With LDT Final Rule Now Null, Industry Groups Urge Lab Managers and Pathologists to Advocate for Change
CAP and AMP officials weigh in on plans to push for a legislative- or CLIA-based approach to future LDT oversight
LDT Appeal: Looking at the Legal Nuances Behind Potential FDA Actions Following Court Decision
Marginal LDT scenarios could be where the FDA focuses on next, a lawyer notes
Illumina, Sequenom Settle Suits Involving Prenatal Tests
...
Already a member? Log in here
CMS Proposes New Shared Savings Risk Model
...
Already a member? Log in here
OIG Efforts Expected to Recover $4.9 Billion in Improper Payments in FY 2014
...
Already a member? Log in here
Leaders of Republican Doctors Caucus See No Action on SGR During Lame Duck
...
Already a member? Log in here
CMS Releases New CLIA-Waived Tests, Billing Codes
...
Already a member? Log in here
Enforcement Trends — Labs Continue to Be a Focus
...
Already a member? Log in here
EBOLA Continues to Warrant Attention From Labs
...
Already a member? Log in here
ACLA Issues White Paper Arguing Against FDA Regulation of LDT
...
Already a member? Log in here